The chemical class designated as TIGD4 Activators encompasses a diverse range of compounds that share the common feature of being able to initiate a cascade of events which leads to the activation of the TIGD4 protein within cellular systems. These activators work through various mechanisms that converge on the regulation of gene expression and chromatin remodeling. By targeting the epigenetic machinery, certain members of this class can facilitate the unwinding of DNA from nucleosomes, thus granting the transcriptional machinery greater access to previously condensed genomic regions. This access can lead to increased transcription of a variety of genes, including those that are otherwise silenced under normal cellular conditions. Other members of this class focus on inhibiting the function of DNA methyltransferases, thereby reducing the methylation status of DNA and promoting the expression of genes that are typically silenced due to heavy methylation.
In addition to affecting DNA methylation, some chemicals within the TIGD4 Activators class function by inhibiting histone deacetylases (HDACs), which results in hyperacetylation of histones. This hyperacetylation results in a more open chromatin state that can facilitate the transcription of many genes. By manipulating the balance of histone acetylation and deacetylation, these activators can lead to an environment that favors gene expression, which includes the upregulation of TIGD4. The effects of these chemicals are not isolated to the activation of TIGD4 alone but extend to a broad array of genomic responses. This broad activity stems from the central role that epigenetic modification plays in regulating gene expression across the genome. As such, these activators interact with cellular pathways that are fundamental to the operation of the epigenome and transcriptome, influencing the expression patterns of multiple genes and modifying the behavior of the cell on a systemic level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can alter chromatin structure, potentially increasing the accessibility of transcription factors to the TIGD4 gene and activating it. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Histone deacetylase inhibitor that can affect gene transcription profiles, potentially leading to the activation of TIGD4. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Inhibits acetaldehyde dehydrogenase and can modulate proteasome activity, which may affect transcription factor activity related to TIGD4 and activate it. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
NF-κB pathway inhibitor that may influence inflammatory response genes and potentially activate TIGD4 through changes in gene regulatory networks. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Phosphodiesterase inhibitor that elevates intracellular cAMP levels, which can modulate various signaling pathways and potentially activate TIGD4. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor that can alter cellular signaling and gene expression, potentially activating TIGD4. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Sirtuin activator that can influence histone and DNA modification, potentially leading to changes in gene expression that activate TIGD4. | ||||||